ARCHIVES

Feds Set Guidelines For Pharma To Help Patients With Cost Of Drugs, While Steering Clear Of Anti-Kickback Law.

This article is from The Cancer Letter archive.

Vol. 32 No. 16 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

In Congress: NCI Apologizes For Delay In Report On Radioactive Fallout

September 18, 1998

CCOP Review Committees Listed

February 6, 1987

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

Clinical Research Programs Could Be Accredited, IOM Says.

April 20, 2001

Cervical Screening Should Emphasize Older Women, ASP Members Told

March 14, 1986

Low-Dose Tamoxifen May Be Effective In Treating Breast Cancer, Study Finds

April 25, 2003